159 results
424B3
EX-31.1
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
424B3
f3k3ps
20 Nov 23
Prospectus supplement
9:38am
424B3
EX-31.2
ax3t2ye778xep7
20 Nov 23
Prospectus supplement
9:38am
424B3
1wxmfl
2 Oct 23
Prospectus supplement
1:42pm
UPLOAD
mk1ucylncsx
27 Sep 23
Letter from SEC
12:00am
8-K
EX-10.2
co7ke 9c7w5xyi5
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm